MedTrace Logo

Tissue Quality of Integra vs. BTM Treated Burns

NCT06760611 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2026-01-07

No results posted yet for this study

Summary

An observational analysis of Integra-treated burns and Novosorb Biodegradable Temporizing Matrix (BTM)-treated burns will be undertaken 12-36 months post final skin graft application by retrospectively analyzing the patient's electronic medical record, and prospectively using a non-invasive measures of tissue quality and patient-reported outcomes. Patients will be offered the option to consent for a tissue biopsy for pathological evaluation.

Conditions

  • Burn Injury
  • Burn Scar
  • Burn Wounds - Partial Thickness (2nd Degree)
  • Skin Grafting

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    lead INDUSTRY

Principal Investigators

  • Yi Arnold · Medical Affairs

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2025-09-30
Completion
2025-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06760611 on ClinicalTrials.gov